Tocilizumab in Treatment for Patients With COVID-19

JAMA Intern Med. 2021 Jul 1;181(7):1017-1018. doi: 10.1001/jamainternmed.2021.0392.

Authors

Chengliang Yang¹, Mingyao Liu^{1

2}

Affiliations

¹ Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
² Institute of Medical Science, Departments of Surgery, Medicine and Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.

PMID: 33818614
DOI: 10.1001/jamainternmed.2021.0392

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized
COVID-19 Drug Treatment*
Humans
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
tocilizumab